Nanoco Group PLC

AGM Statement

RNS Number : 3185K
Nanoco Group PLC
13 December 2018

13 December 2018


("Nanoco", the "Group", or the "Company")


AGM Statement

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other specific nanomaterials emanating from our technology platform, will hold its Annual General Meeting ("AGM") later this morning at its headquarters in Manchester.

Dr Christopher Richards, Nanoco's Chairman, will make the following statement in respect of the Group's trading performance in the first four months of the financial year ending 31 July 2019 ('the Period').

"Since we updated the market in mid-October with our preliminary results, we have continued to make good progress in delivering the various scopes of work for our US Customer for materials used in the electronics industry. Our Runcorn facility expansion remains on track to be completed by the end of the current calendar year and we continue to deliver excellent performance in enhancing the quality and performance of our next generation materials. The Runcorn plant will enter its next development phase in January 2019 when it will undergo commissioning and stress testing prior to commercial volume manufacture early in the first half of the next financial year.

"In CFQD and Display, our focus has been on enhancing the performance of our materials. Here too we are delivering improved results to our licensees and application partners.

"We continue to work with a range of customers and partners on a number of near term potentially transformative technological and commercial activities. These opportunities span a wide range of applications and end markets, emphasizing the platform nature of our unique, patent protected nano-material technology. These opportunities will support the business as it transitions through this exciting phase in our evolution. We remain confident in delivering the Board's expectations for our full year results."

- Ends -


For further information, please contact:



Tel: +44 (0) 161 603 7900

Brian Tenner, Company Secretary

Caroline Watson, Investor Relations Manager

Tel: + 44 (0) 7799 897357

[email protected]


Notes for editors:


About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-materials. .Nano-materials are materials with dimensions typically in the range 1 - 100 nm. Nano-materials have a range of useful properties, including optical and electronic. Quantum dots are a subclass of nano-material that have size-dependent optical and electronic properties. The Group produces quantum dots. Within the sphere of quantum dots, the Group exploits different characteristics of the quantum dots to target different performance criteria that are attractive to specific markets or end-user applications such as the Display and Electronics markets. One of the interesting properties of quantum dots is photoluminescence: the emission of longer wavelength light upon excitation by light of a shorter wavelength. The colour of light emitted depends on the particle size. Nanoco's CFQD® quantum dots are free of cadmium and other toxic heavy metals, and can be tuned to emit light at different wavelengths across the visible and infrared spectrum, rendering them useful for a wide range of applications including displays, lighting and biological imaging.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit:

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit